Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: How lucky are the lucky ones?

Journal of Clinical Oncology

Volumn 25, Issue 15, 2007, Pages 2049-2056

  Liavaag, Astrid H ^a   Dørum, Anne ^a   Fosså, Sophie D ^a   Tropé, Claes ^a   Dahl, Alv A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; TAMOXIFEN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANXIETY; ARTICLE; BODY IMAGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVOR; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FATIGUE; FEMALE; FOLLOW UP; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; CROSS-SECTIONAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; NEOPLASM; NORWAY; OVARY TUMOR; QUESTIONNAIRE; SURVIVOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MORBIDITY; NEOPLASMS, GLANDULAR AND EPITHELIAL; NORWAY; OVARIAN NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVORS;

EID: 34249933159     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.1769     Document Type: Article

References (18)

1. Stewart DE, Wong F, Duff S, et al: What doesn't kill you makes you stronger: An ovarian cancer survivor survey. Gynecol Oncol 83:537-542, 2001
2. Lockwood-Rayermann S: Survivorship issues in ovarian cancer: A review. Oncol Nurs Forum 33:553-562, 2006
3. Holzner B, Kemmler G, Meraner V, et al: Fatigue in ovarian carcinoma patients: A neglected issue. Cancer 97:1564-1572, 2003
4. Wenzel LB, Donnelly JP, Fowler JM, et al: Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study. Psychooncology 11:142-153, 2002
5. Berek JS, Hacker NF: Practical Gynecologic Oncology (ed 4). Philadelphia, PA, Lippincott, Williams and Wilkins, 2005, pp 443-494
6. Friedlander ML: Prognostic factors in ovarian cancer. Semin Oncol 25:305-314, 1998
7. Thorsen L, Nystad W, Stigum H, et al: The association between self-reported physical activity and prevalence of depression and anxiety in long-term survivors of testicular cancer and in general population sample. Support Care Cancer 13:637-646, 2005
8. Chalder T, Berelowitz G, Pawlikowska T, et al: Development of a fatigue scale. J Psychosom Res 37:147-153, 1993
9. Bjelland I, Dahl AA, Tangen T, et al: The validity of the Hospital Anxiety and Depression Scale. J Psychosom Res 52:69-77, 2002
10. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international trials in oncology. J Natl Cancer Inst 85:365-376, 1993
11. Hopwood P, Fletcher I, Lee A, et al: A body image scale for use with cancer patients. Eur J Cancer 37:189-197, 2001
12. Holmen J, Midthjell K, Krüger Ö, et al: The Nord-Tröndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation. Nor Epidemiol 13:19-32, 2003
13. Norwegian University of Science and Technology: HUNT. http://www.hunt.ntnu.no/
14. Cohen J: Statistical Power Analysis for the Behavioral Sciences (ed 2). Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
15. Hales RE, Yudosky SC, Talbott JA The American Psychiatric Press Textbook of Psychiatry (ed 3). Washington, DC, American Psychiatric Press, 1999
16. Sogaard AJ, Selmer R, Bjertness E, et al: The Oslo Health Study: The impact of self-selection in a large, population-based survey. Int J Equity Health 3:3, 2004
17. Selmer R, Sogaard AJ, Bjertness E, et al: The Oslo Health study: Reminding the non-responders - effects on prevalence estimates. Nor Epidemiol 13:89-94, 2003
18. Stigum H, Magnus P, Veierod M, et al: Impact on sexually transmitted disease spread of increased condom use by young females, 1987-1992. Int J Epidemiol 24:813-820, 1995